PLSE
Price
$13.01
Change
+$0.35 (+2.76%)
Updated
Nov 21 closing price
Capitalization
881.66M
124 days until earnings call
Intraday BUY SELL Signals
STXS
Price
$2.32
Change
+$0.08 (+3.57%)
Updated
Nov 21 closing price
Capitalization
216.51M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PLSE vs STXS

Header iconPLSE vs STXS Comparison
Open Charts PLSE vs STXSBanner chart's image
Pulse Biosciences
Price$13.01
Change+$0.35 (+2.76%)
Volume$304.36K
Capitalization881.66M
Stereotaxis
Price$2.32
Change+$0.08 (+3.57%)
Volume$554.12K
Capitalization216.51M
PLSE vs STXS Comparison Chart in %
PLSE
Daily Signal:
Gain/Loss:
STXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PLSE vs. STXS commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLSE is a Hold and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (PLSE: $13.01 vs. STXS: $2.32)
Brand notoriety: PLSE and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PLSE: 166% vs. STXS: 90%
Market capitalization -- PLSE: $881.66M vs. STXS: $216.51M
PLSE [@Pharmaceuticals: Other] is valued at $881.66M. STXS’s [@Pharmaceuticals: Other] market capitalization is $216.51M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $199.09B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLSE’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • PLSE’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, STXS is a better buy in the long-term than PLSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLSE’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 4 bullish TA indicator(s).

  • PLSE’s TA Score: 5 bullish, 5 bearish.
  • STXS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PLSE is a better buy in the short-term than STXS.

Price Growth

PLSE (@Pharmaceuticals: Other) experienced а -9.65% price change this week, while STXS (@Pharmaceuticals: Other) price change was +4.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.94%. For the same industry, the average monthly price growth was +2.64%, and the average quarterly price growth was +10.24%.

Reported Earning Dates

PLSE is expected to report earnings on Mar 26, 2026.

STXS is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-0.94% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSE($882M) has a higher market cap than STXS($217M). STXS YTD gains are higher at: 1.754 vs. PLSE (-25.273). STXS has higher annual earnings (EBITDA): -22.41M vs. PLSE (-71.1M). PLSE has more cash in the bank: 106M vs. STXS (6.97M). STXS has less debt than PLSE: STXS (5.73M) vs PLSE (8.25M). STXS has higher revenues than PLSE: STXS (31.8M) vs PLSE (0).
PLSESTXSPLSE / STXS
Capitalization882M217M406%
EBITDA-71.1M-22.41M317%
Gain YTD-25.2731.754-1,441%
P/E RatioN/AN/A-
Revenue031.8M-
Total Cash106M6.97M1,521%
Total Debt8.25M5.73M144%
FUNDAMENTALS RATINGS
PLSE vs STXS: Fundamental Ratings
PLSE
STXS
OUTLOOK RATING
1..100
5765
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
8764
P/E GROWTH RATING
1..100
10048
SEASONALITY SCORE
1..100
8590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLSE's Valuation (83) in the Medical Specialties industry is in the same range as STXS (99). This means that PLSE’s stock grew similarly to STXS’s over the last 12 months.

PLSE's Profit vs Risk Rating (97) in the Medical Specialties industry is in the same range as STXS (100). This means that PLSE’s stock grew similarly to STXS’s over the last 12 months.

PLSE's SMR Rating (97) in the Medical Specialties industry is in the same range as STXS (100). This means that PLSE’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (64) in the Medical Specialties industry is in the same range as PLSE (87). This means that STXS’s stock grew similarly to PLSE’s over the last 12 months.

STXS's P/E Growth Rating (48) in the Medical Specialties industry is somewhat better than the same rating for PLSE (100). This means that STXS’s stock grew somewhat faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLSESTXS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 30 days ago
85%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
PLSE
Daily Signal:
Gain/Loss:
STXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHDCX8.870.21
+2.42%
American Beacon Shapiro SMID Cap Eq C
AUENX21.460.17
+0.80%
AQR Large Cap Defensive Style N
FOCIX14.42N/A
N/A
Fairholme Focused Income
FEQTX29.85N/A
N/A
Fidelity Equity Dividend Income
HWSIX70.66N/A
N/A
Hotchkis & Wiley Small Cap Value I

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+2.76%
CERS - PLSE
38%
Loosely correlated
+8.05%
BLFS - PLSE
36%
Loosely correlated
+9.63%
STXS - PLSE
36%
Loosely correlated
+3.57%
CLPT - PLSE
32%
Poorly correlated
+2.22%
ARAY - PLSE
32%
Poorly correlated
+11.71%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+3.57%
SMTI - STXS
42%
Loosely correlated
+1.78%
TWST - STXS
36%
Loosely correlated
+9.59%
NVST - STXS
36%
Loosely correlated
+4.08%
PLSE - STXS
35%
Loosely correlated
+2.76%
CERS - STXS
35%
Loosely correlated
+8.05%
More